EBR Systems' (ASX:EBR) WiSE system was accepted into the Centers for Medicare & Medicaid Services' Transitional Coverage for Emerging Technologies reimbursement pathway, according to a Monday filing with the Australian bourse.
WiSE technology is a wireless pacing system designed to stimulate the heart's left ventricle.
The pathway is designed to expedite Medicare coverage for a select group of breakthrough devices designated by the US Food and Drug Administration, enabling early access to innovative medical technologies, the filing said.
Shares rose nearly 1% in midday trade Monday and earlier reached an all-time high.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.